USSTOCK.TODAY
Pre-Market
Log in Sign up
ETF Profiles

AIBF ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs

Updated October 3, 2026 · First published October 3, 2026

The iShares Future AI Beneficiaries ETF (AIBF) invests in US companies expected to cut costs and lift revenue by adopting artificial intelligence. It is a thematic ETF worth examining for its exposure to AI-related stocks centered on adopters rather than semiconductor makers, as well as its outlook and fee level.

Briefs · earnings · signals, first Subscribe
🏷️

What Is the iShares Future AI Beneficiaries ETF?

The fund tracks an index of US companies expected to benefit from the adoption of artificial intelligence. It treats cost reduction as the main channel of benefit and uses revenue growth as a secondary criterion when selecting stocks.

It suits investors who want to avoid concentration in semiconductors and Big Tech while targeting the second-order beneficiaries of AI's spread.

The ETF is passively managed (index tracking) by BlackRock iShares.

💰

How Does the iShares Future AI Beneficiaries ETF Invest?

ItemDetails
Tracked indexUS AI beneficiaries index (see the issuer's official materials)
Management stylePassive (index tracking)
Rebalancing frequencyFollows index rules (check official materials)
Dividend/distribution frequencyNot yet determined (check official materials)
IssuerBlackRock iShares
Expense ratio0.40%

Instead of the semiconductor, cloud and model companies that develop artificial intelligence directly, the fund holds companies that apply AI to their operations to lower costs and grow revenue. Traditional sectors such as retail, pharmaceuticals and biotech, and consumer staples carry large weights.

  • Portfolio centered on AI adopters rather than AI suppliers
  • Large weights in pharmaceuticals, biotech and consumer staples make its exposure different from existing AI ETFs
  • Diversified portfolio of roughly one hundred holdings
📐

iShares Future AI Beneficiaries ETF Size and Costs (AUM and Management Fee)

Assets under management (AUM) stand at $248.0M, and the expense ratio is 0.40% per year.

As a thematic ETF, its fee is higher than that of broad index ETFs, and because it is a new product, it is wise to check trading volume and bid-ask spreads as well.

📈

iShares Future AI Beneficiaries ETF Performance and Trends

1-Year Price Performance
Dividend & Yield
No dividend or yield data available
52-Week Price Range
$26
Low $25 High $26
vs. low +4.62% vs. high 0.08%

As a new fund, it has a short long-term return history. Because many of its holdings are defensive large caps, its return pattern is likely to differ from that of tech-focused AI ETFs.

The product launched as investor interest in AI broadens from semiconductors to adopting companies. Its asset size is small to mid-sized, and fund flows vary with market interest in the theme.

⚔️

iShares Future AI Beneficiaries ETF Pros and Cons

Its strength is diversified exposure that avoids overconcentration in AI suppliers, while its weaknesses are a short track record and uncertainty in how the theme is defined.

💪 Key Strengths

Exposure centered on adopters
Little overlap with existing AI investments skewed toward semiconductors and Big Tech, so diversification benefits are expected.
Defensive sector weighting
Large weights in consumer staples and pharmaceuticals suggest relatively lower volatility.
Large issuer infrastructure
It draws on BlackRock iShares' fund management and index oversight systems.

⚠️ Points to Watch

Short track record
Having just launched, it lacks the data needed to judge performance and tracking error.
Uncertain theme effect
It is hard to predict when and how much the effects of AI adoption will show up in earnings.
Sector concentration
Large pharmaceutical and biotech weights expose it to sector-specific regulatory and clinical trial risks.
Fee burden
Its fee is higher than that of broad index ETFs.
🔄

iShares Future AI Beneficiaries ETF Alternative and Related ETFs

Because no comparable ETFs appear in the comparison table, alternatives are outlined here by strategy. ARTY, from the same issuer, concentrates on companies that supply AI technology, so its exposure is almost the opposite of this ETF. AIQ also centers on artificial intelligence and technology companies, so holding the two products together would cover both suppliers and adopters.

Peer Comparison ETFs
TickerNamePriceChangeAUMTotal Expense RatioDividend Yield1Y
DYNFDYNFiShares U.S. Equity Factor Rotation Active ETF$69.44+0.6%$42.5B0.26%0.81%+16.8%
AVUVAVUVAvantis U.S. Small Cap Value ETF$120.92-0.0%$31.4B0.25%1.26%+22.4%
FNDXFNDXSchwab Fundamental U.S. Large Company ETF$32.71+0.1%$28.3B0.25%1.44%+23.3%
USMVUSMViShares MSCI USA Min Vol Factor ETF$102.41+0.1%$24.0B0.15%1.38%+8.1%
SPMOSPMOInvesco S&P 500 Momentum ETF$143.15+0.8%$22.0B0.13%0.77%+18.6%
✅

iShares Future AI Beneficiaries ETF Investor Checkpoints

These are the points to review before investing in this ETF. Because its theme definition differs from existing AI ETFs, it is best to first confirm what the fund actually invests in, then look at costs and liquidity.

CheckpointWhat to CheckCurrent Status
🧭 Understanding the themeConfirm the portfolio centers on AI adoptersLow supplier weighting
💵 Expense ratioReview the fee level for a thematic ETFHigher than broad ETFs
💧 LiquidityCheck trading volume and bid-ask spreadsNeeds checking as a new product
📊 Sector weightsCheck for skew toward pharmaceuticals and consumer staplesLarge defensive sector weighting

If the effects of AI adoption do not translate into earnings, the rationale for the theme weakens. With a short track record and large weights in certain sectors, the fund can at times move in a different direction from the overall market.

It can serve as a complementary asset for investors who want to add diversification to AI investing centered on semiconductors and Big Tech. We suggest starting with a small position and adjusting it as the fund's track record builds.

Briefs · earnings · signals, first Subscribe

Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.

This article reflects information as of October 3, 2026.

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →